Terns Pharmaceuticals Inc... (TERN)

NASDAQ: TERN · Real-Time Price · USD

2.94

0.02 (0.68%)

At close: Apr 28, 2025, 3:59 PM

2.87

-2.55%

After-hours: Apr 28, 2025, 04:34 PM EDT

Terns Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q1 2020	Q4 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Mar 31, 2020	Dec 31, 2019
Cash & Equivalents	161.44M	270.14M	91.5M	65.1M	79.93M	37.89M	80.92M	184.35M	143.24M	62.98M	16.81M	43.88M	47.7M	64.75M	67.59M	98.83M	74.85M	13.76M	-19.65M	12.33M
Short-Term Investments	196.72M	102.64M	133.8M	175.56M	183.51M	228.71M	204.68M	113.17M	139.88M	124.31M	123M	107.39M	118.28M	112.44M	117.5M	96.75M	n/a	n/a	39.3M	7.32M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	350K	56K	55K	55K	56K	35K	36K	2.17M	37K	47K	64K	72K	94K	169K	176K	174K	246K	758K	-19.65M	719K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	12.72M	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.97M	n/a	n/a	n/a
Other Current Assets	3.94M	3.73M	4.94M	5.24M	3.99M	n/a	2.71M	2.14M	2.07M	3.25M	2.79M	2.84M	948K	1.6M	1.79M	2.46M	2.14M	1.67M	n/a	461K
Total Current Assets	362.11M	376.51M	230.24M	245.9M	267.43M	270.45M	288.31M	297.53M	285.19M	190.54M	142.6M	154.11M	166.93M	178.79M	186.87M	198.04M	90.87M	15.42M	19.65M	22.22M
Property-Plant & Equipment	1.47M	1.67M	587K	816K	1.03M	1.2M	1.35M	1.58M	1.8M	2M	2.19M	2.49M	1.05M	927K	959K	1.02M	1.18M	1.23M	n/a	961K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.82M	1.73M	642K	871K	1.08M	1.23M	1.38M	3.76M	1.84M	2.05M	2.26M	2.56M	1.14M	1.1M	1.14M	1.2M	1.42M	1.99M	-19.65M	1.68M
Total Assets	363.93M	378.23M	230.88M	246.77M	268.52M	271.69M	289.7M	301.29M	287.03M	192.59M	144.86M	156.67M	168.07M	179.89M	188.01M	199.24M	92.29M	17.41M	n/a	23.9M
Account Payables	2.15M	1.79M	1.87M	1.7M	2.52M	3.33M	5.54M	2.69M	1.65M	2.09M	973K	1.68M	2.13M	1.58M	1.69M	4.25M	935K	461K	n/a	1.64M
Deferred Revenue	n/a	n/a	2.05M	1.22M	n/a	7.66M	1.09M	n/a	n/a	n/a	n/a	n/a	n/a	836K	836K	836K	836K	7.67M	n/a	n/a
Short-Term Debt	n/a	n/a	249K	n/a	603K	n/a	653K	656K	n/a	665K	586K	584K	n/a	n/a	n/a	n/a	12.88M	19.34M	n/a	n/a
Other Current Liabilities	8.37M	4.76M	5.48M	532K	5.36M	4.36M	5.61M	7.28M	185K	2.06M	2.58M	2.64M	358K	3.08M	2.34M	2.79M	6.68M	555K	n/a	117K
Total Current Liabilities	15.65M	11.41M	10.96M	8.83M	11.94M	12.09M	14.24M	12.11M	8.47M	7.48M	6.04M	6.17M	6.82M	6.89M	5.82M	8.38M	22.82M	28.02M	n/a	4.95M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	1.49M	1.32M	1.24M	1.22M	1.21M	1.11M	1.09M	1.11M	1.07M	709K	749K	788K	947K	841K	857K	862K	877K	13.88M	n/a	14.4M
Total Long-Term Liabilities	2.41M	2.35M	1.24M	1.22M	1.21M	1.18M	1.31M	1.49M	1.61M	1.41M	1.6M	1.79M	947K	841K	857K	862K	877K	14.24M	n/a	14.75M
Total Liabilities	18.06M	13.76M	12.2M	10.05M	13.15M	13.26M	15.55M	13.6M	10.08M	8.89M	7.64M	7.95M	7.77M	7.73M	6.67M	9.24M	23.7M	42.26M	n/a	19.7M
Total Debt	1.35M	1.3M	249K	427K	603K	770K	876K	1.04M	1.21M	1.37M	1.44M	1.58M	n/a	n/a	n/a	n/a	12.88M	19.34M	n/a	n/a
Common Stock	9K	8K	7K	6K	6K	6K	6K	5K	5K	4K	3K	3K	3K	3K	3K	3K	n/a	n/a	n/a	n/a
Retained Earnings	-421.48M	-399.68M	-377.74M	-355M	-332.63M	-311.61M	-281.84M	-263.95M	-242.42M	-226.6M	-209.78M	-195.85M	-182.07M	-167.82M	-155.99M	-145.25M	-131.91M	-121.99M	n/a	-91.86M
Comprehensive Income	-279K	160K	-443K	-321K	-19K	-836K	-775K	-416K	-822K	-1.35M	-1.24M	-896K	-338K	-167K	-174K	-232K	-124K	90K	-90.76M	-106K
Shareholders Equity	345.87M	364.47M	218.68M	236.72M	255.37M	258.43M	274.15M	287.68M	276.94M	183.69M	137.22M	148.72M	160.3M	172.16M	181.33M	190M	68.59M	-24.85M	18.32M	4.21M
Total Investments	196.72M	102.64M	133.8M	175.56M	183.51M	228.71M	204.68M	113.17M	139.88M	124.31M	123M	107.39M	118.28M	112.44M	117.5M	96.75M	n/a	n/a	39.3M	7.32M